SEC Form 4 reporting owner

Lin Elizabeth Yeu

Lin Elizabeth Yeu has filed 14 Form 4 transactions reported between December 15, 2025 and September 4, 2026, as Chief Medical Officer of Tarsus Pharmaceuticals, Inc..

Name as filed: Lin Elizabeth Yeu

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$2.2M

10 lines

Companies

with Form 4 filings

Latest transaction

Sep 4, 2026

transaction date

Roles and reported holdings

TARSTarsus Pharmaceuticals, Inc.
Dec 15, 2025 – Sep 4, 2026
Chief Medical Officer
Held directly2,547 sh as of Sep 4, 2026 · Form 4
Held indirectly (latest line)3,180 sh as of Sep 4, 2026 · Form 4
24 months: $2.2M sold

Transaction history

All 14 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Sep 4, 2026	TARSChief Medical Officer	Open-market saleCode S · indirect	1,590	$85.00	$135K@ $85.00	3,180	Form 4
Sep 4, 2026	TARSChief Medical Officer	Open-market saleCode S · direct	5,386	$90.00	$485K@ $90.00	2,547	Form 4
Sep 4, 2026	TARSChief Medical Officer	Open-market saleCode S · direct	5,387	$85.00	$458K@ $85.00	7,933	Form 4
Sep 2, 2026	TARSChief Medical Officer	Open-market saleCode S · indirect	1,590	$80.00	$127K@ $80.00	4,770	Form 4
Sep 2, 2026	TARSChief Medical Officer	Open-market saleCode S · direct	5,387	$80.00	$431K@ $80.00	13,320	Form 4
Sep 1, 2026	TARSChief Medical Officer	Open-market saleCode S · direct	4,601	$73.86	$340K@ $73.86	18,707	Form 4
Mar 19, 2026	TARSChief Medical Officer	Open-market saleCode S · direct	390	$67.00	$26K@ $67.00	23,308	Form 4
Mar 18, 2026	TARSChief Medical Officer	Open-market saleCode S · direct	379	$68.71	$26K@ $68.71	23,698	Form 4
Mar 17, 2026	TARSChief Medical Officer	Open-market saleCode S · direct	375	$69.42	$26K@ $69.42	24,077	Form 4
Mar 15, 2026	TARSChief Medical Officer	Option exerciseCode M · direct	2,511	—	—	24,452	Form 4
Mar 5, 2026	TARSChief Medical Officer	Grant or awardCode A · direct	17,161	—	—	17,161	Form 4
Mar 5, 2026	TARSChief Medical Officer	Grant or awardCode A · direct	27,310	—	—	27,310	Form 4
Dec 16, 2025	TARSChief Medical Officer	Open-market saleCode S · direct	2,078	$79.50	$165K@ $79.50	21,941	Form 4
Dec 15, 2025	TARSChief Medical Officer	Option exerciseCode M · direct	6,819	—	—	24,019	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.